THE International Air Cargo Association (TIACA) and Pharma.Aero has teamed up to help with the guidance for the air cargo industry on the transportation of Covid-19 vaccines, reports London's Air Cargo News.
The process is in four packages through a joint working group and the guidance will help ensure feedback from stakeholders of air cargo and pharmaceuticals.
The results will be distributed throughout the industry with white papers and webinars, which is expected to be finished by the end of 2020.
'The aim of this programme is to provide the air cargo industry with more clarity of the demands, expectations, and quality supply chain requirements, including but not restricted to critical trade lanes, air cargo capacity, handling, and storage, track and trace requirements, for the transportation of the vaccines,' said TIACA.
'At the same time, shippers will gain more understanding about the capabilities of the various logistics players. This will ensure that once the vaccine is available in the market, the air cargo industry will be ready to respond to the needs of the shippers and transport vaccines in optimal conditions to all corners of the globe.' said TIACA.'Covid-19 vaccine delivery will be one of the biggest logistical challenges in modern history. No one company can own the end-to-end vaccine supply chain,' said TIACA board member and global head of air freight at Flexport, Neel Jones Shah.
'Setting up reliable end-to-end air transportation for pharma shippers is part of the vision and mission of Pharma.Aero. Among our members ie, life sciences and pharmaceutical shippers, certified airport communities, and air cargo operators, we have a track record of project-based collaboration.' said Pharma.Aero chairman Nathan De Valck.
'As a result, Pharma.Aero is well-positioned to make a valuable contribution in preparing the air cargo industry for this immense challenge.' said Mr De Valck.
SeaNews Turkey
The process is in four packages through a joint working group and the guidance will help ensure feedback from stakeholders of air cargo and pharmaceuticals.
The results will be distributed throughout the industry with white papers and webinars, which is expected to be finished by the end of 2020.
'The aim of this programme is to provide the air cargo industry with more clarity of the demands, expectations, and quality supply chain requirements, including but not restricted to critical trade lanes, air cargo capacity, handling, and storage, track and trace requirements, for the transportation of the vaccines,' said TIACA.
'At the same time, shippers will gain more understanding about the capabilities of the various logistics players. This will ensure that once the vaccine is available in the market, the air cargo industry will be ready to respond to the needs of the shippers and transport vaccines in optimal conditions to all corners of the globe.' said TIACA.'Covid-19 vaccine delivery will be one of the biggest logistical challenges in modern history. No one company can own the end-to-end vaccine supply chain,' said TIACA board member and global head of air freight at Flexport, Neel Jones Shah.
'Setting up reliable end-to-end air transportation for pharma shippers is part of the vision and mission of Pharma.Aero. Among our members ie, life sciences and pharmaceutical shippers, certified airport communities, and air cargo operators, we have a track record of project-based collaboration.' said Pharma.Aero chairman Nathan De Valck.
'As a result, Pharma.Aero is well-positioned to make a valuable contribution in preparing the air cargo industry for this immense challenge.' said Mr De Valck.
SeaNews Turkey